WILMINGTON, Del. - Prelude Therapeutics (NASDAQ:PRLD) announced Tuesday it will prioritize development of its mutant selective JAK2V617F JH2 inhibitor and KAT6A selective degrader programs while ...
The final, formatted version of the article will be published soon. Oral squamous cell carcinoma (OSCC) is a highly invasive head and neck malignancy with poor prognosis and limited treatment efficacy ...
Nintendo showcased live gameplay of eight upcoming Switch 2 titles during the first day of its “Nintendo Treehouse: Live – Nintendo Switch 2” broadcast. Games showcased on the first day included Mario ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback